Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research

Daily mango (Mangifera indica L.) consumption supplemented with probiotics differentially modulates inflammation and cognitive function in individuals with overweight or obesity: a placebo-controlled, double-blind, and randomized trial.

  • 2026
  • Food & function 17(2)
    • Hyemee Kim
    • Kevin B Kiefer
    • Shannon E Schmidt-Combest
    • Giuliana Noratto
    • Shirley Arbizu
    • Maria Joselyn Castellon Chicas
    • Nicos C Georghiades
    • Steven E Riechman
    • Colin D Kay
    • Rodrigo San-Cristobal
    • Stephen T Talcott
    • Susanne U Mertens-Talcott

Study Design

Type
Randomized Controlled Trial (RCT)
Population
Fifty lean participants (BMI 18-23 kg m^{-2}) and 44 overweight/obese participants (BMI 27-35 kg m^{-2}) aged 18-65
Methods
Double-blind, randomized, controlled pilot study; 8 weeks of 400 g fresh mango with one placebo/probiotics capsule
Blinding
Double-blind
Duration
8 weeks
Funding
Unclear
  • Rigorous Journal
Mango, rich in gallotannins with antioxidant and anti-inflammatory properties, may enhance cognitive performance in overweight/obese individuals. However, bioavailability of mango polyphenol metabolites is reduced in this population. Probiotics may improve bioavailability by hydrolyzing parent compounds into smaller molecules. Main objective of this double-blind, randomized, controlled pilot study was to evaluate whether 8 weeks of mango and probiotic intake would enhance microbial gallotannin-metabolite levels, reduce inflammation, and improve cognitive function in overweight/obese individuals. Fifty lean participants (BMI 18-23 kg m-2) and 44 overweight/obese participants (BMI 27-35 kg m-2) aged 18-65 consumed 400 g of fresh mango with one placebo/probiotics capsule for 8 weeks. Cognitive function tests and blood collections occurred on days 1 and 54, with additional visual cognitive tests between days 43-54. Mango plus probiotics significantly reduced plasma Δ TNF-α in overweight/obese participants but had no effect in lean participants. Lean individuals showed improved cognitive performance (Trail Making Test A and Digit Span scores), while overweight/obese participants improved only in Digit Span Backward. Gallotannin-metabolites increased in lean participants regardless of treatment but increased only with probiotic intake in overweight/obese participants. Microbiota analysis identified enrichment of Lactobacillus and Lachnospiraceae in the mango-probiotics group, while Clostridium and Streptococcus decreased. Overweight/obese participants with higher systemic exposure to gallotannin-metabolites showed improved Δ IL-1β, Δ total ghrelin, and Δ PYY. Despite probiotic supplementation, low metabolite producers had increased Firmicutes and Clostridiaceae. Overall, probiotics enhanced cognitive performance in lean participants, while attenuated inflammation and improved cognitive function in overweight/obese participants, likely due to increased systemic exposure to gallotannin-metabolites.

Research Insights

  • overweight/obese participants improved only in Digit Span Backward

    Effect
    Neutral
    Effect size
    Small
    Dose
    400 g fresh mango per day + one placebo capsule per day
  • overweight/obese participants improved only in Digit Span Backward

    Effect
    Neutral
    Effect size
    Small
    Dose
    400 g fresh mango per day + one placebo capsule per day
  • Mango plus probiotics significantly reduced plasma Δ TNF-α in overweight/obese participants but had no effect in lean participants

    Effect
    Neutral
    Effect size
    Small
    Dose
    400 g fresh mango per day + one placebo capsule per day
Back to top